146 related articles for article (PubMed ID: 29660352)
1. Outcomes in a Community-Based Intensive Cardiac Rehabilitation Program: Comparison with Hospital-Based and Academic Programs.
Katzenberg C; Silva E; Young MJ; Gilles G
Am J Med; 2018 Aug; 131(8):967-971. PubMed ID: 29660352
[TBL] [Abstract][Full Text] [Related]
2. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.
Izquierdo-Porrera AM; Gardner AW; Powell CC; Katzel LI
J Vasc Surg; 2000 Apr; 31(4):670-7. PubMed ID: 10753274
[TBL] [Abstract][Full Text] [Related]
3. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
Sacks FM; Carey VJ; Anderson CA; Miller ER; Copeland T; Charleston J; Harshfield BJ; Laranjo N; McCarron P; Swain J; White K; Yee K; Appel LJ
JAMA; 2014 Dec; 312(23):2531-41. PubMed ID: 25514303
[TBL] [Abstract][Full Text] [Related]
4. Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease.
Lavie CJ; Milani RV
Chest; 1996 Jan; 109(1):52-6. PubMed ID: 8549217
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training.
Lavie CJ; Milani RV
Arch Intern Med; 1993 Apr; 153(8):982-8. PubMed ID: 8481069
[TBL] [Abstract][Full Text] [Related]
6. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?
Holcombe SM; Brubaker PH
J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073
[TBL] [Abstract][Full Text] [Related]
7. The impact of complex cardiac rehabilitation on manifestation of risk factors in patients with coronary heart disease.
Kubilius R; Jasiukevičienė L; Grižas V; Kubilienė L; Jakubsevičienė E; Vasiliauskas D
Medicina (Kaunas); 2012; 48(3):166-73. PubMed ID: 22588350
[TBL] [Abstract][Full Text] [Related]
8. Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease.
Mailander L; Lavie CJ; Milani RV; Gaudin D
South Med J; 1993 May; 86(5):508-12. PubMed ID: 8488395
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
[TBL] [Abstract][Full Text] [Related]
10. Reduction in Cardiovascular Risk Among Latino Participants in a Community-Based Intervention Linked With Clinical Care.
Krantz MJ; Beaty B; Coronel-Mockler S; Leeman-Castillo B; Fletcher K; Estacio RO
Am J Prev Med; 2017 Aug; 53(2):e71-e75. PubMed ID: 28602543
[TBL] [Abstract][Full Text] [Related]
11. Effects of a contemporary, exercise-based rehabilitation and cardiovascular risk-reduction program on coronary patients with abnormal baseline risk factors.
Franklin B; Bonzheim K; Warren J; Haapaniemi S; Byl N; Gordon N
Chest; 2002 Jul; 122(1):338-43. PubMed ID: 12114378
[TBL] [Abstract][Full Text] [Related]
12. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
[TBL] [Abstract][Full Text] [Related]
13. The obesity paradox, weight loss, and coronary disease.
Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice.
Świątkiewicz I; Di Somma S; De Fazio L; Mazzilli V; Taub PR
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836144
[TBL] [Abstract][Full Text] [Related]
15. Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format.
Milsom VA; Malcolm RJ; Johnson GC; Pechon SM; Gray KM; Miller-Kovach K; Rost SL; O'Neil PM
Eat Behav; 2014 Jan; 15(1):68-71. PubMed ID: 24411753
[TBL] [Abstract][Full Text] [Related]
16. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of the Complete Health Improvement Program (CHIP) in Australasia for reducing selected chronic disease risk factors: a feasibility study.
Morton DP; Rankin P; Morey P; Kent L; Hurlow T; Chang E; Diehl H
N Z Med J; 2013 Mar; 126(1370):43-54. PubMed ID: 23474512
[TBL] [Abstract][Full Text] [Related]
18. Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease.
El Missiri A; Abdel Halim WA; Almaweri AS; Mohamed TR
Egypt Heart J; 2021 Jan; 73(1):4. PubMed ID: 33411160
[TBL] [Abstract][Full Text] [Related]
19. Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease.
Lavie CJ; Milani RV
Am J Cardiol; 1994 Dec; 74(12):1192-5. PubMed ID: 7977088
[TBL] [Abstract][Full Text] [Related]
20. Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.
Deedwania PC; Shepherd J; Breazna A; DeMicco DA;
Diabetes Obes Metab; 2016 Jan; 18(1):56-63. PubMed ID: 26434404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
